US Edition
News from Selvita
Top Selvita News
Poland · PolandThe Management Board of Selvita S.A. with its registered office in Krakow (“Company”) hereby announces that the following shareholders controlled at least 5% of the votes at the General Shareholders Meeting of the Company (“GSM”) convened on June 30, 2025:
Paweł Przewięźlikowski 2,943,160 shares of the Company, which entitled to exercise 5,875,160 votes, representing 30.89% of the shares at the GSM, and 45.16% of the votes at the GSM, and 26.90…Read Article
Shareholders controlling at least 5% of the votes at the General Shareholders Meeting of Selvita S.A. convened on June 30, 2025
Poland · PolandThe Management Board of Selvita S.A., with its registered office in Kraków (the “Company”), hereby informs that on June 30, 2025, the Ordinary General Meeting of the Company appointed the Members of the Supervisory Board for a new term of office in the following composition:
Mr. Piotr Romanowski – Chairman of the Supervisory Board; Mr. Tadeusz Wesołowski – Vice Chairman of the Supervisory Board; Mr. Paweł Przewięźlikowski – Member of the Superv…See the Story
Appointment of Members of the Supervisory Board of Selvita S.A. for a New Term of Office
Kraków · KrakówThe Management Board of Selvita S.A., with its registered office in Kraków (the “Issuer” or the “Company”), hereby informs that on June 26, 2025, the Issuer’s subsidiary – Selvita Inc. – received two orders for the provision of services (the “Orders”) from a biotechnology company headquartered in the United States (the “Client”). The Orders pertain to the continuation of work under the Client’s integrated drug discovery program, performed under …Read Article
Receipt of a significant order by a company affiliated with Selvita S.A.
You've scrolled to the bottom of the feed, there are no more stories.
